Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758569
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus PhotographsDemocritus University of ThraceRecruiting
NCT07758569Recruiting
—
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device...Democritus University of...
NCT07756918
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International UniversityRecruitingNot Applicable
NCT07756918Recruiting
Not Applicable
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International Univ...
NCT07758387
Polydextrose Functional Gummies for Weight Management in Adults With Overweight or ObesityNutris We Care About You S.L.Not Yet RecruitingNot Applicable
NCT07758387Not Yet Recruiting
Not Applicable
Polydextrose Functional Gummies for Weight Management in Adults With Overweight...Nutris We Care About You...
NCT07758426
Effects of Tummy Time Associated With Therapeutic Positioning in Premature Newborns With Cranial AsymmetryHospital de Clinicas de Porto AlegreNot Yet RecruitingNot Applicable
NCT07758426Not Yet Recruiting
Not Applicable
Effects of Tummy Time Associated With Therapeutic Positioning in Premature Newbo...Hospital de Clinicas de P...
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07757711
Implementation of New Models of Ovarian Carcinoma Resistant to TherapyIstituto Europeo di OncologiaNot Yet Recruiting
NCT07757711Not Yet Recruiting
—
Implementation of New Models of Ovarian Carcinoma Resistant to TherapyIstituto Europeo di Oncol...
NCT07758868
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City HospitalNot Yet Recruiting
NCT07758868Not Yet Recruiting
—
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City Hospita...
NCT07759050
Clinical Study of Spectral CTPhilips Clinical & Medical Affairs GlobalNot Yet RecruitingNot Applicable
NCT07759050Not Yet Recruiting
Not Applicable
Clinical Study of Spectral CTPhilips Clinical & Medica...
NCT07758101
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative ColitisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 1
NCT07758101Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and i...Guangdong Hengrui Pharmac...
NCT07758985
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.London School of Hygiene and Tropical MedicineNot Yet RecruitingPhase 1
NCT07758985Not Yet Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner...London School of Hygiene...
NCT07758127
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology CenterNot Yet Recruiting
NCT07758127Not Yet Recruiting
—
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology Center
NCT07758673
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic LymphomaCity of Hope Medical CenterNot Yet RecruitingPhase 1
NCT07758673Not Yet Recruiting
Phase 1
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed o...City of Hope Medical Cent...
NCT07758920
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaShanghai Yidian Pharmaceutical Technology Development Co., Ltd.RecruitingPhase 2
NCT07758920Recruiting
Phase 2
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Tr...Shanghai Yidian Pharmaceu...
NCT07757230
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerShenyang Sunshine Pharmaceutical Co., LTD.Not Yet RecruitingPhase 2
NCT07757230Not Yet Recruiting
Phase 2
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low o...Shenyang Sunshine Pharmac...
NCT07757906
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal DissectionQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07757906Not Yet Recruiting
Not Applicable
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADT...Qilu Hospital of Shandong...
NCT07757828
Efficacy of PRF in Hypospadias RepairAin Shams UniversityNot Yet RecruitingNot Applicable
NCT07757828Not Yet Recruiting
Not Applicable
Efficacy of PRF in Hypospadias RepairAin Shams University
NCT07757555
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia InternationalNot Yet RecruitingEarly Phase 1
NCT07757555Not Yet Recruiting
Early Phase 1
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia Internationa...
NCT07758777
Usability Evaluation of the Intelligent Fingerprinting Drug Screening SystemIntelligent Bio Solutions Inc.CompletedNot Applicable
NCT07758777Completed
Not Applicable
Usability Evaluation of the Intelligent Fingerprinting Drug Screening SystemIntelligent Bio Solutions...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting4 (20%)
Completed2 (10%)
not_applicable7 (35%)
Not Specified6 (30%)
Phase 14 (20%)
Phase 22 (10%)
Early Phase 11 (5%)